Ann Arbor, MI –  March 10, 2011 - Swift Biosciences Inc. today announced that Steve Spotts has joined the company as Chief Commercial Officer.

Click here to download a PDF of the press release.

Ann Arbor, MI –  Feb 24, 2011 - Swift Biosciences Unveils qPCR Primer Tech; Hopes to Market First Product by Year's End

"Swift this week publicly presented the first research results for its core technology, a new kind of highly sensitive qPCR primer designed for mutation and low copy number detection, and said it would eventually market products in the research, diagnostics, and next-generation sequencing spaces."

Read the full article at www.GenomeWeb.com

San Francisco, CA –  February 23, 2011 - Swift Biosciences Inc., a developer of innovative genetic analysis tools for the research and diagnostic markets, today presented at 18th International Molecular Medicine Tri-Conference their high performance qPCR myT™ Primers for highly sensitive, highly specific detection of cancer mutations.

Click here to download a PDF of the press release.

Ann Arbor, MI – August 10, 2010 – Swift Biosciences Inc., a Michigan-based life sciences company, today announced the recent completion of a $3 million Series A financing led by the venture firm DFJ Mercury. DFJ Mercury was joined in the Series A by several Michigan-based individual investors who also helped launch the Company with seed funding in January 2010.

Click here to download a PDF of the press release.